Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results

March 15, 2024

https://www.globenewswire.com/news-release/2024/03/15/2846980/0/en/Cognition-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Results.html

PURCHASE, N.Y., March 15, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq:CGTX), a clinical-stage neuroscience company developing product candidates designed to treat neurodegenerative disorders by regulating cellular damage response pathways, today announced that the Company will release financial results for the fourth quarter and full year ended December 31, 2023 on Tuesday, March 26, 2024 before the market open. Following the release, management will host a conference call at 8:00 a.m. ET on the same day to review the financial and operating results and provide a business update.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.